Drugs and Human Performance Fact Sheets: 2024
archive: archived pipeline: cataloged verified
Get this paper ↗ (full text — opens at the source; we link to it, we don't host it)
Summary
This document, titled *Drugs and Human Performance Fact Sheets: 2024*, is a comprehensive technical report published by the National Highway Traffic Safety Administration (NHTSA) to address the critical issue of driving under the influence of psychoactive substances. The primary motivation for this publication is the need for standardized, scientifically grounded methods to identify, assess, and document drug-impaired drivers. The report aims to provide practical guidance for interpreting chemical test results and evaluating impairment, targeting a diverse audience including drug recognition experts, law enforcement officers, attorneys, judges, toxicologists, and public health researchers. It serves as a revised edition of previous reports from 2004 and 2014, incorporating the latest scientific research to ensure accuracy in legal and safety contexts. The methodology involves a systematic review and synthesis of existing scientific literature regarding the pharmacology, pharmacokinetics, and performance effects of various drugs. An expert panel contributed to the development of the report, ensuring that the information reflects current best practices. The document is organized into detailed fact sheets for specific substances and drug classes, including ethanol, amphetamines, benzodiazepines (such as alprazolam, clonazepam, diazepam, and lorazepam), cannabinoids, cocaine, opioids, and others. Each fact sheet provides structured data on synonyms, sources, clinical and non-clinical uses, potency, routes of administration, and pharmacodynamics. Crucially, the report details pharmacokinetic parameters, such as blood-to-plasma ratios and oral fluid-to-blood concentration ratios, to aid in the interpretation of test results from blood, urine, and oral fluid specimens. It also outlines general effects, duration of action, tolerance, dependence, and withdrawal symptoms. The findings presented in the fact sheets summarize evidence from laboratory studies, simulated driving studies, on-the-road driving studies, epidemiological studies, and case reports. For each substance, the report categorizes the drug within the Drug Evaluation and Classification Program (DECP) and provides a specific DECP profile to assist in field identification. The document highlights interactions between drugs, particularly with ethanol, and discusses analytical considerations for testing. By compiling this data, the report establishes clear guidelines for interpreting blood alcohol concentrations (BAC) and other drug levels in relation to impairment, offering a standardized reference for determining whether a driver’s performance is compromised by specific substances. The significance of this report lies in its role as a definitive resource for bridging the gap between scientific research and practical application in traffic safety and law enforcement. It provides the necessary tools for professionals to accurately assess drug-impaired driving cases, thereby supporting consistent legal proceedings and enhancing public safety. By updating the scientific basis for drug impairment assessment, the NHTSA ensures that stakeholders have access to current, evidence-based information. This facilitates more effective identification of impaired drivers, improves the reliability of chemical evidence in court, and supports broader efforts in driver education and public health advocacy regarding the dangers of drug-impaired driving.
Key finding
The report provides a consolidated scientific resource detailing the pharmacological properties and driving-related effects of numerous psychoactive substances to aid in the identification and assessment of drug-impaired drivers.
Methodology
review
Provenance
The full processing record for this entry. Every stage of this paper's journey through the pipeline is logged — what ran, with which tool and model, how many attempts it took, and when it last completed. Discovered via bulk_ingest_rosap on 2026-05-23 (29 acquisition events logged).
| Stage | Outcome | Tool | Model | Prompt | Attempts | Completed |
|---|---|---|---|---|---|---|
| discover | success | rosap | — | — | 2 | 2026-05-23 |
| archive | success | — | — | — | 1 | 2026-05-23 |
| extract | success | cached | — | — | 2 | 2026-06-10 |
| clean | success | — | — | — | 1 | 2026-06-01 |
| chunk | success | — | — | — | 1 | 2026-06-01 |
| embed | success | — | — | — | 1 | 2026-06-02 |
| enrich | success | — | — | — | 1 | 2026-05-23 |
| promote | success | — | — | — | 1 | 2026-05-23 |
| summarize | success | llm | qwen3.6-27b-prismaquant | summ-v5 | 26 | 2026-06-10 |
| tag | success | vector_similarity | — | — | 19 | 2026-06-11 |
| verify | success | — | — | — | 2 | 2026-06-10 |
Summary generated by qwen3.6-27b-prismaquant on 2026-06-10; verification: verified.
Topics
Ranked by relevance to this paper. Hover a topic for its definition.